CMX Research: Clinical Trials

9 completed, 1 suspended, 1 unknown. 2 Not applicable, 2 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 3.

By phase and status

Phase	Trials	Status
Not applicable	2	Completed 1, Suspended 1
Phase 2	2	Completed 1, Unknown 1
Early Phase 1	1	Completed 1
Phase 1	1	Unknown 1
Phase 3	1	Completed 1

Follow CMX Research: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Trial to Assess the Safety and Clinical Performance of Contino® in Preventing Urinary Incontinence Contino - Urinary Incontinence	Not applicable	Suspended	CMX Research	25	2019-11-19	2025-02-20
First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients. ORCA-010 - Adenocarcinoma of the Prostate	Phase 1 / Phase 2	Unknown	Orca Therapeutics B.V.	24	2019-11-12	2023-10-31
A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer 2-Hydroxyflutamide Depot - Prostate Cancer	Phase 2	Completed	Lidds AB	61	2017-05-12	2020-12-21
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer Goserelin Acetate - Prostate Cancer	Early Phase 1	Completed	CMX Research	11	2017-02-21	2021-05-10
Trial to Assess the Efficacy of the Comfort Plug™in Preventing Urinary Incontinence (COMFORT STUDY) Comfort Plug™ - Urinary Incontinence	Not applicable	Completed	CMX Research	30	2014-02-04	2020-06-11
PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training Cancer of the Prostate		Completed	CMX Research	271	2013-11-01	2022-01-24
Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study Prostate Cancer		Completed	AbbVie (prior sponsor, Abbott)	552	2011-06-28	2018-12-13
Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists Prostate Cancer		Completed	CMX Research	125	2011-03-01	2016-12-22
Eligard Observational Registry for Patients With Prostate Cancer Cancer of the Prostate		Completed	CMX Research	354	2009-08-01	2016-12-22
Bone Health Observational Study Prostate Cancer		Completed	CMX Research	599	2007-09-01	2017-09-28
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer risedronate, Control - Prostate Cancer	Phase 3	Completed	CMX Research	160	2007-01-01	2012-02-03

Conditions studied

Prostatic Neoplasms (9)  ·  Prostatic Hyperplasia (2)  ·  Urinary Incontinence (2)  ·  Adenoviridae Infections (1)

Interventions

Goserelin (1)  ·  Risedronic Acid (1)

Countries

Canada (10)  ·  Finland (1)  ·  Georgia (1)  ·  Lithuania (1)

Top investigators

Richard Casey, MD (3)  ·  Richard W Casey, M.D. (2)  ·  Alvaro Morales, M.D. (1)  ·  Christina Pelizon, MD (1)  ·  Cornelis Groen, BSc Law, PhD (1)  ·  Dean Elterman, MD (1)  ·  Richard Casey, M.D. (1)

NIH funding

2017 (1)